Group items tagged

The cerebrospinal fluid (CSF) management market is segmented by product, end user, and region. Based on product, the market is segmented into shunts and external drainage systems. The shunts market is expected to grow at the highest CAGR during the forecast period. The high growth in the shunts market can be primarily attributed to the growing number of shunting procedures performed worldwide as well as the increasing number of revision shunt surgeries. Based on the type, the shunts segment is further segmented into ventriculoperitoneal (VP), ventriculoatrial (VA), lumboperitoneal (LP), and ventriculopleural (VPL).

The US Food and Drug Administration (FDA) has issued a statement warning healthcare providers about potential complications in patients fitted with both programmable cerebrospinal fluid (CSF) shunt systems and certain magnetic hearing devices.

Researchers have identified two genetically distinct types of HIV in the cerebrospinal fluid (CSF) of patients with HIV-associated dementia.